THE EFFECT OF THE CALCIUM-CHANNEL AGONIST, BAY K-8644 ON HUMAN VASCULAR SMOOTH-MUSCLE

被引：37

作者：

GOPALAKRISHNAN, V ^{[1
]}

PARK, LE ^{[1
]}

TRIGGLE, CR ^{[1
]}

机构：

[1] MEM UNIV NEWFOUNDLAND,FAC MED,DIV BASIC MED SCI,ST JOHNS A1B 3V6,NEWFOUNDLAND,CANADA

来源：

EUROPEAN JOURNAL OF PHARMACOLOGY | 1985年 / 113卷 / 03期

关键词：

D O I：

10.1016/0014-2999(85)90095-0

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：447 / 451

页数：5

共 10 条

[1]

BELLEMANN P, 1981, ARZNEIMITTEL-FORSCH, V31-2, P2064

[2]

BOLGER GT, 1983, J PHARMACOL EXP THER, V225, P291

[3] SPECIFIC PHARMACOLOGY OF CALCIUM IN MYOCARDIUM, CARDIAC-PACEMAKERS, AND VASCULAR SMOOTH-MUSCLE [J].

FLECKENSTEIN, A .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1977, 17 :149-166

[4] SPECIFIC HIGH-AFFINITY BINDING OF THE CALCIUM-CHANNEL ANTAGONIST, [H-3] NITRENDIPINE, TO RAT-LIVER MICROSOMES [J].

GOPALAKRISHNAN, V ;

TRIGGLE, CR .

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1984, 62 (09) :1249-1252

[5] PN-200-110, A NEW CALCIUM-ANTAGONIST - ELECTROPHYSIOLOGICAL, INOTROPIC, AND CHRONOTROPIC EFFECTS ON GUINEA-PIG MYOCARDIAL TISSUE AND EFFECTS ON CONTRACTION AND CALCIUM-UPTAKE OF RABBIT AORTA [J].

HOF, RP ;

SCHOLTYSIK, G ;

LOUTZENHISER, R ;

VUORELA, HJ ;

NEUMANN, P .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1984, 6 (03) :399-406

[6] CORONARY VASODILATOR AND CARDIAC EFFECTS OF OPTICAL ISOMERS OF VERAPAMIL IN THE DOG [J].

SATOH, K ;

YANAGISAWA, T ;

TAIRA, N .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1980, 2 (03) :309-318

[7] NOVEL DIHYDROPYRIDINES WITH POSITIVE INOTROPIC ACTION THROUGH ACTIVATION OF CA-2+ CHANNELS [J].

SCHRAMM, M ;

THOMAS, G ;

TOWART, R ;

FRANCKOWIAK, G .

NATURE, 1983, 303 (5917) :535-537

[8] CELLULAR ACTION OF CALCIUM-CHANNEL BLOCKING-DRUGS [J].

SCHWARTZ, A ;

TRIGGLE, DJ .

ANNUAL REVIEW OF MEDICINE, 1984, 35 :325-339

[9] CALCIUM-CHANNEL ACTIVATION IN VASCULAR SMOOTH-MUSCLE BY BAY K-8644 [J].

SU, CM ;

SWAMY, VC ;

TRIGGLE, DJ .

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1984, 62 (11) :1401-1410

[10]

TOWART R, 1982, ARZNEIMITTEL-FORSCH, V32, P1338

← 1 →